User profiles for Siddharthan Chandran
 | Siddharthan ChandranEdinburgh University Verified email at ed.ac.uk Cited by 19925 |
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models
…, X Li, D Peisach, C Shaw, S Chandran… - Nature chemical …, 2014 - nature.com
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have distinct clinical
features but a common pathology—cytoplasmic inclusions rich in transactive response …
features but a common pathology—cytoplasmic inclusions rich in transactive response …
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43
TDP-43 is a predominantly nuclear RNA-binding protein that forms inclusion bodies in
frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The mRNA …
frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The mRNA …
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
…, A Compston, MA Scott, DH Miller, S Chandran - The Lancet …, 2012 - thelancet.com
Background More than half of patients with multiple sclerosis have progressive disease
characterised by accumulating disability. The absence of treatments for progressive multiple …
characterised by accumulating disability. The absence of treatments for progressive multiple …
Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived …
…, R Layfield, A Compston, S Chandran - Journal of …, 2003 - Soc Neuroscience
Interactions of CNS cells lead to the establishment of complex neural systems. Specifically,
oligodendrocytes form myelin sheaths around axons that enable rapid electrical conduction …
oligodendrocytes form myelin sheaths around axons that enable rapid electrical conduction …
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in
amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-…
amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-…
ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS
…, K Lonergan, T Chiwera, T Booth, S Chandran… - Neurology, 2018 - AAN Enterprises
Objective To elucidate the relationship between disease stage in amyotrophic lateral sclerosis
(ALS), as measured with the King's Clinical Staging System, and cognitive and behavioral …
(ALS), as measured with the King's Clinical Staging System, and cognitive and behavioral …
Improving the translational hit of experimental treatments in multiple sclerosis
…, A Williams, S Chandran… - Multiple Sclerosis …, 2010 - journals.sagepub.com
Background: In other neurological diseases, the failure to translate pre-clinical findings to
effective clinical treatments has been partially attributed to bias introduced by shortcomings in …
effective clinical treatments has been partially attributed to bias introduced by shortcomings in …
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled …
…, R Bastow, CJ Weir, N Stallard, S Chandran… - The Lancet …, 2020 - thelancet.com
Background Neurodegeneration is the pathological substrate that causes major disability in
secondary progressive multiple sclerosis. A synthesis of preclinical and clinical research …
secondary progressive multiple sclerosis. A synthesis of preclinical and clinical research …
[PDF][PDF] Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations
The RNA-binding protein TDP-43 regulates RNA metabolism at multiple levels, including
transcription, RNA splicing, and mRNA stability. TDP-43 is a major component of the …
transcription, RNA splicing, and mRNA stability. TDP-43 is a major component of the …
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
…, JS Mora, R Rojas-García, M Polak, S Chandran… - Nature …, 2016 - nature.com
To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find
associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced …
associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced …
